|
|
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen
,
Stéphan Vagner
,
Caroline Robert
Journal articles
hal-03493495v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Hélène Malka-Mahieu
,
Michelle Newman
,
Laurent Désaubry
,
Caroline Robert
,
Stéphan Vagner
Journal articles
hal-03533702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib
Phillippe Saiag
,
Caroline Robert
,
Jean Jacques Grob
,
Laurent Mortier
,
Olivier Dereure
,
et al.
Journal articles
hal-03401780v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study
Sandrine Monestier
,
Stéphane Dalle
,
Laurent Mortier
,
Caroline Dutriaux
,
Sophie Dalac-Rat
,
et al.
Journal articles
hal-03287366v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy
Assia Asrir
,
Claire Tardiveau
,
Juliette Coudert
,
Robin Laffont
,
Lucas Blanchard
,
et al.
Journal articles
hal-03576428v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
Sophie Viaud
,
Magali Terme
,
Caroline Flament
,
Julien Taieb
,
Fabrice André
,
et al.
Journal articles
pasteur-03360096v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Paolo Antonio Ascierto
,
Michelle del Vecchio
,
Andrzej Mackiewicz
,
Caroline Robert
,
Vanna Chiarion-Sileni
,
et al.
Journal articles
inserm-03709901v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
Michaël Cerezo
,
Abdelali Lehraiki
,
Antoine Millet
,
Florian Rouaud
,
Magali Plaisant
,
et al.
Journal articles
hal-01357448v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines
Hélène Malka-Mahieu
,
Isabelle Girault
,
Margot Rubington
,
Melissa Leriche
,
Caroline Welsch
,
et al.
Journal articles
hal-03536458v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Paolo A Ascierto
,
Michele Del Vecchio
,
Caroline Robert
,
Andrzej Mackiewicz
,
Vanna Chiarion-Sileni
,
et al.
Journal articles
inserm-01807340v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
Bernard Escudier
,
Thierry Dorval
,
Nathalie Chaput
,
Fabrice André
,
Marie-Pierre Caby
,
et al.
Journal articles
inserm-00092539v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou
,
Jonathan M. Pitt
,
Romain Daillere
,
Patricia Lepage
,
Nadine Waldschmitt
,
et al.
Journal articles
hal-02639698v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.
Cédric Ménard
,
Jean-Yves Blay
,
Christophe Borg
,
Stefan Michiels
,
François Ghiringhelli
,
et al.
Journal articles
inserm-00484764v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force
Claus Garbe
,
Ketty Peris
,
Efthymia Soura
,
Ana Maria Forsea
,
Axel Hauschild
,
et al.
Journal of the European Academy of Dermatology and Venereology, 2020, 34 (10), pp.2183-2197. ⟨10.1111/jdv.16849⟩
Journal articles
hal-02984280v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Breast cancer following radiotherapy for a hemangioma during childhood.
Nadia Haddy
,
Marie-Gabrielle Dondon
,
Catherine Paoletti
,
Carole Rubino
,
Abdeddahir Mousannif
,
et al.
Journal articles
istex
inserm-00609937v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1
Julien Rossignol
,
Zakia Belaid
,
Guillemette Fouquet
,
Flavia Guillem
,
Rachel Rignault
,
et al.
Journal articles
hal-03842485v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FREQUENCY AND GENOMIC ASPECTS OF INTRINSIC RESISTANCE TO VISMODEGIB IN LOCALLY ADVANCED BASAL CELL CARCINOMA
Andrey Yurchenko
,
Oltin Pop
,
Meriem Ighilahriz
,
Ismael Padioleau
,
Fatemeh Rajabi
,
et al.
Journal articles
inserm-03544184v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting
Vahé Asvatourian
,
Clélia Coutzac
,
Nathalie Chaput
,
Caroline Robert
,
Stefan Michiels
,
et al.
Journal articles
inserm-02310420v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy
Léa Dousset
,
Florence Poizeau
,
Caroline Robert
,
Sandrine Mansard
,
Laurent Mortier
,
et al.
Journal articles
inserm-03525310v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy
Nadia Haddy
,
Tianarimanana Andriamboavonjy
,
Catherine Paoletti
,
Marie-Gabrielle Dondon
,
Abdeddahir Mousannif
,
et al.
Journal articles
istex
inserm-00460601v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks
Michael Migden
,
Carmen Loquai
,
Caroline Robert
,
Jean- François Baurain
,
Nicholas Squittieri
,
et al.
Journal articles
inserm-03818996v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover
Celeste Lebbé
,
Caroline Dutriaux
,
Thierry Lesimple
,
Willem Kruit
,
Joseph Kerger
,
et al.
Journal articles
hal-03256625v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Hélène Malka-Mahieu
,
Michelle Newman
,
Laurent Desaubry
,
Caroline Robert
,
Stephan Vagner
Journal articles
hal-03533711v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering
Ana I Romero
,
Nathalie Chaput
,
Vichnou Poirier-Colame
,
Sylvie Rusakiewicz
,
Nicolas Jacquelot
,
et al.
Journal articles
inserm-02442721v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|